Arvelle Therapeutics committed to patients and Healthcare Professionals through the implementation of the IT solution „Arvato CSDB“
Arvelle Therapeutics International GmbH entered into a partnership with Arvato Systems for the serialization of “Cenobamate”, a potential anti-seizure investigational drug in Europe Arvelle set to implement the serialization solution "Arvato CSDB" in accordance to the pharmaceutical EU Falsified Medicines Mehr